Preliminary results of endovascular abdominal aortic aneurysm exclusion with the AneuRx stent-graft.

OBJECTIVES: This study evaluated the clinical effectiveness of the Medtronic AneuRx stent-graft in patients with infrarenal abdominal aortic aneurysms (AAAs) who were treated in an endovascular suite. BACKGROUND: The use of endovascular stent-graft prosthesis for the treatment of AAAs is receiving increasing attention as an alternative to standard surgical repair. Endovascular treatment of AAAs offers the potential to avoid the significant morbidity and mortality associated with surgical repair. METHODS: In this series, 215 patients have undergone AAA exclusion with the AneuRx stent-graft. Six-month follow-up is available in 132 patients; one-year follow-up is available in 84 and two-year follow-up in 22. RESULTS: Of the patients, one hundred ninety-two (89%) were male; 87% had hypertension, and 58.6% were American Society of Anesthesiologists grade IV or higher. The procedural success was 99.5%; we were unable to place the device in one patient. There was no procedural or one-month mortality. There were no acute conversions to surgical repair. One patient had a non-Q-wave myocardial infarction 24 h after the procedure. Endoleaks were present in 82 patients (42%) at discharge, 15 patients (11.3%) at six months and 10 patients (11.9%) at one year. Twenty-two patients had a secondary procedure for endoleak repair of which three were conversions to surgical repair. Twelve late deaths have occurred, none due to device failure or AAA rupture. Mean hospital stay was 1.9 days. CONCLUSIONS: These results reveal that infrarenal AAAs can be safely and successfully treated in an endovascular suite with the AneuRx stent-graft. Further follow-up is needed to determine the long-term efficacy of endoluminal treatment to prevent rupture and death due to AAAs.

Inflammatory aneurysms of the aorta.

This report concerns 30 patients with the acute form of "inflammatory aneurysm" of the aorta treated during a 27-year period between April 1957 and March 1984. There were 28 men and two women whose ages ranged from 46 to 78 years (most over 60 years). All were heavy smokers. The aneurysmal disease was located below the renal arteries and the inflammatory changes were limited to the abdomen in 24 patients; one patient had a ruptured aneurysm. The aneurysm involved the entire abdominal aorta in one, the descending thoracic and infrarenal abdominal aorta in two, and the descending thoracic and abdominal aorta in continuity in three patients. The inflammatory changes occurred grossly and microscopically in both abdominal and thoracic aortic segments in five of the latter six patients. The changes were manifested by anterior and lateral mural inflammatory thickening contiguous with similar changes of the retroperitoneum and mediastinum that produced varying degrees of ureteral obstruction in seven patients. Most had abdominal, back, or flank pain and abdominal tenderness, suggesting rupture or leakage. Emergency exploratory operation had been performed elsewhere in 10 patients. Operation was abandoned because of exposure difficulties, bowel perforation, or visceral arterial involvement. Diagnosis was suggested by CT scan in 10, ultrasonography in one, and excretory urograms in seven patients. Treatment consisted of thoracoabdominal aortic replacement in six and infrarenal aortic replacement in 24. The aorta was clamped at the diaphragm in most of the latter cases to avoid injury to adjacent structures. Nephrectomy or ureterolysis was rarely necessary. Of these 30 patients, 29 were early (30 day) survivors and ureteral obstruction spontaneously subsided in most cases without special treatment. There was one late death at 2 months and eight deaths from 3 to 13 years; 20 (67%) patients are still alive.